SRE
54
-5
SHW
53
-2
JNJ
60
-2
MSI
35
-3
CPB
39
2
NVDA
47
-5
PFG
68
-5
GILD
47
-5
PNR
66
-2
LUV
68
-2
VRTX
52
3
XOM
50
-3
NEE
52
-2
ICE
67
-2
ABT
41
3
EXPE
85
-3
AAP
12
-14
QCOM
44
-5
DOW
43
-5
CTAS
37
-5
SRE
54
-5
SHW
53
-2
JNJ
60
-2
MSI
35
-3
CPB
39
2
NVDA
47
-5
PFG
68
-5
GILD
47
-5
PNR
66
-2
LUV
68
-2
VRTX
52
3
XOM
50
-3
NEE
52
-2
ICE
67
-2
ABT
41
3
EXPE
85
-3
AAP
12
-14
QCOM
44
-5
DOW
43
-5
CTAS
37
-5
Financhill
Back

JPMorgan US Tech Leaders ETF Vs. Nektar Therapeutics Industry Stock Comparison

Sell
40

JTEK
JPMorgan US Tech Leaders ETF

Last Price:
$89.85
Seasonality Move:
2.11%
Sell
39

NKTR
Nektar Therapeutics

Last Price:
$54.70
Seasonality Move:
11.58%
Sell
40
JPMorgan US Tech Leaders ETF (JTEK) is a Sell

Is JPMorgan US Tech Leaders ETF a Buy, Sell or Hold?

  • The current JPMorgan US Tech Leaders ETF [JTEK] share price is $89.93. The Score for JTEK is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • JTEK is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $54.70. The Score for NKTR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

JTEK Stock Price Chart

What is JPMorgan US Tech Leaders ETF's stock price today?

  • The JPMorgan US Tech Leaders ETF share price today is $89.93
    The current trend is moderately bearish and JTEK is experiencing selling pressure, which indicates risk of future bearish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $54.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

JTEK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.22 Buy
Relative Strength Index (14 RSI): 45.11 Sell
Chaikin Money Flow: -106769 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (87.78 - 93) Sell
Bollinger Bands (100): (85.66 - 93.58) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.71 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 141668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.71 - 61.07) Sell
Bollinger Bands (100): (32.74 - 62.56) Buy

JTEK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 92.15 Sell
20-day SMA: 89.9 Buy
50-day SMA: 92.11 Sell
200-day SMA: 82.15 Buy
8-day EMA: 91.62 Sell
20-day EMA: 91.23 Sell
50-day EMA: 89.26 Buy
200-day EMA: 55.79 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.42 Sell
20-day SMA: 58.12 Sell
50-day SMA: 58.41 Sell
200-day SMA: 30.65 Buy
8-day EMA: 56.16 Sell
20-day EMA: 57.43 Sell
50-day EMA: 55.78 Sell
200-day EMA: 37.86 Buy

JPMorgan US Tech Leaders ETF Earnings Growth & JTEK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

JPMorgan US Tech Leaders ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):